menu search

Guided bone regeneration market estimated to surpass us$ 1.2 billion by 2033, dental implants propel growth | persistence market research

Market Study on Guided Bone regeneration: Bone Graft Substitutes Accounts for Over Two-third Market Sha...

September 18, 2023, 1:53 pm

Collplant biotechnologies announces date for 2023 second quarter financial results and conference call information

-  Conference call to be held on Thursday, August 24, 2023 at 10:00 a.m. U.S. EDT - REHOVOT, Israel, Aug. 9, 2023 /PRNewswire/ -- CollPlant Biotechno...

August 9, 2023, 9:02 am

Jacobs (j), mace partner for the ellinikon program in greece

Jacobs (J) and Mace's joint venture is set to manage the Ellinikon development program, the largest urban rege...

June 29, 2023, 1:39 pm

Nuscale power ($smr) demonstrates emission reducing capabilities of small modular reactors

New research from NuScale Power (NYSE: SMR) has demonstrated the advanced capabilities of NuScale small modular reactors (SMRs) for reducing emissions...

May 31, 2023, 2:06 pm

Biocardia presentations at next generation cardiovascular drug development summit now available

SUNNYVALE, Calif., April 28, 2023 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the...

April 28, 2023, 11:00 am

Pliant therapeutics' bexotegrast shows promise for idiopathic pulmonary fibrosis

Pliant Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative therapies for fibrosis, inflammation, and related d...

March 3, 2023, 10:48 am

Surrozen to present at the 41st annual j.p. morgan healthcare conference

SOUTH SAN FRANCISCO, Calif., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a company pioneeri...

January 4, 2023, 4:41 pm

Pluristem (psti) phase iii study misses goal, stock down

Pluristem (PSTI) phase III study of muscle regeneration following hip fracture surgery evaluating PLX-P...

July 14, 2022, 12:24 pm

Pluristem posts mixed results from study of muscle regeneration after hip fracture surgery

Pluristem Therapeutics Inc (NASDAQ: PSTI) announced topline results from its Phase 3 study of intramuscular administration of allogeneic PLX-PAD ce...

July 13, 2022, 9:59 am

Ortho regenerative technologies is at the forefront of regenerative medicine with its elegantly simple tissue repair technology

Ortho Regenerative Technologies Inc (CSE:ORTH) is developing novel tissue repair therapies with the goal of dramatically increasing the success rates ...

June 3, 2022, 8:15 am

Mediwound to present at upcoming investor conferences in february

YAVNE, Israel, Feb. 14, 2022 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company focused on next-generatio...

February 14, 2022, 9:03 am

Mediwound to present at upcoming investor conferences in february

YAVNE, Israel, Feb. 14, 2022 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company focused on next-generatio...

February 14, 2022, 9:03 am

Mediwound to present at upcoming investor conferences in february

YAVNE, Israel, Feb. 14, 2022 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company focused on next-generatio...

February 14, 2022, 9:03 am

Researchers identify thymosin beta 4's potential role in treatment of acute kidney injury and the reduction of mortality in patients with sepsis

ROCKVILLE, Md., Oct. 6, 2021 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("RegeneRx"), a clinical-stage drug development company...

October 6, 2021, 9:20 am

Researchers identify thymosin beta 4's potential role in treatment of acute kidney injury and the reduction of mortality in patients with sepsis

ROCKVILLE, Md., Oct. 6, 2021 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("RegeneRx"), a clinical-stage drug development company...

October 6, 2021, 9:20 am

Researchers identify thymosin beta 4's potential role in treatment of acute kidney injury and the reduction of mortality in patients with sepsis

ROCKVILLE, Md., Oct. 6, 2021 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("RegeneRx"), a clinical-stage drug development company...

October 6, 2021, 9:20 am


Search within

Pages Search Results: